Drake & Associates’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Drake & Associates's LLY Position: Q3 2026 in Review
Drake & Associates increased its Eli Lilly (LLY) stake by 10% in Q3 2026, buying an estimated $143K and bringing the position to 1,334 shares worth $1.54M. The position accounts for 0.24% of the portfolio, ranked #32.
Drake & Associates first reported a position in LLY in Q2 2022 and has held it in 18 quarters since. 4,625 funds tracked by Wall St. Rank hold LLY as of Q3 2026.
- Drake & Associates held 1,334 shares of Eli Lilly worth $1.54M as of Q3 2026.
- Drake & Associates bought 121 Eli Lilly shares in Q3 2026, an estimated $143K.
- Eli Lilly made up 0.24% of Drake & Associates's portfolio in Q3 2026, its #32 holding.
- Drake & Associates first reported a position in Eli Lilly in Q2 2022 and has held it in 18 quarters since.
- 4,625 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.
Based on Drake & Associates's 13F filing for Q3 2026, filed 18 Nov 2026.